Cipra AI
Healthcare Software · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.cipra.aiRevenue
<$5 MillionIndustry
About Cipra AI
Cipra AI Org Chart
Is Cipra AI your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Cipra AI recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if Cipra AI has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Cipra AI has new funding data
Click to see if Cipra AI had a recent Job posting/layoffs
Check out if Cipra AI is spiking on competitors!
Cipra AI, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Cipra AI
Product Launch: Get notified when Cipra AI launches new products
Recommended Actions
Reach out to Masked Content who joined Cipra AI as Masked Content
Find more new buyers
Compare Similar Companies to Cipra AI
Compare insights from companies similar to Cipra AI, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cipra AI Tech Stack
A closer look at the technologies used by Cipra AI
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cipra AI
CIPRA.ai provides an AI-driven platform for the precise care, reversal, and prevention of chronic conditions, specifically focusing on hypertension and diabetes. Founded in July 2022, the company utilizes Agentic AI and digital twins to analyze multimodal data from wearables, including sleep, stress, diet, and vitals, to deliver hyper-personalized... Read More